A bioinformatics platform that predicts, ranks, and designs optimal double-stranded RNA (dsRNA) molecules targeting essential, species-specific transcripts in insect pests. The tool screens over 3,000 insect genomes and transcriptomes, identifies high-penetrance targets, and confirms the absence of off-target effects in non-target species including humans, enabling precise RNA-based pest control in transgenic plants.
This bioinformatics tool addresses a critical bottleneck in RNA interference (RNAi)-based insect pest control: the identification of gene targets that are both essential to the pest and specific enough to avoid harming non-target organisms. The platform automatically analyzes insect genomes and transcriptomes to predict transcripts essential for survival, reproduction, or development, then designs optimal double-stranded RNA (dsRNA) sequences for plant expression. It computationally validates the absence of off-target effects in other animals, including humans, and ranks candidates by predicted efficiency. The resulting database can cover more than 3,000 insect species with available genomic or transcriptomic data, supporting agricultural biotechnology, integrated pest management, and biosafety assessment.
Core capabilities:
Team expertise:
The project is at an early-to-mid development stage. The underlying scientific foundation is well established through a decade of published work in insect genomics, RNAi design, and siRNA mechanism studies. Future validation will involve laboratory confirmation of selected targets and continued computational refinement. The tool is positioned to deliver a functional database and analysis pipeline, with a GUI planned as a future enhancement. The team is seeking collaboration to advance development, validate predictions experimentally, and expand the database to additional species.
Jagiellonian University is a comprehensive public research university in Krakow with a broad academic profile and an integrated medical college connected to a major hospital system. Industry partners engage through co-located core facilities, prototyping and analytical labs, and contract research, with access to a nearby research and technology park and startup incubation. Health system integration supports clinical research and translation with access to patient cohorts and regulated environments. Research is supported by competitive national funding and European Union programs, enabling collaborations that scale across borders. A dedicated technology transfer office manages IP, licensing, and spinout formation and offers industry-friendly agreements to streamline engagement.